Your browser is no longer supported. Please, upgrade your browser.
Settings
RATE Bankrate, Inc. daily Stock Chart
RATE [NYSE]
Bankrate, Inc.
Index- P/E- EPS (ttm)-0.46 Insider Own3.80% Shs Outstand89.19M Perf Week-0.36%
Market Cap1.24B Forward P/E16.81 EPS next Y0.82 Insider Trans-2.51% Shs Float47.56M Perf Month19.40%
Income-40.00M PEG- EPS next Q0.14 Inst Own49.50% Short Float4.31% Perf Quarter39.90%
Sales459.30M P/S2.69 EPS this Y-321.30% Inst Trans-34.58% Short Ratio2.35 Perf Half Y19.91%
Book/sh7.77 P/B1.78 EPS next Y18.22% ROA-3.60% Target Price12.71 Perf Year68.29%
Cash/sh2.06 P/C6.74 EPS next 5Y10.00% ROE-5.80% 52W Range6.91 - 14.25 Perf YTD25.34%
Dividend- P/FCF16.45 EPS past 5Y-21.80% ROI-1.50% 52W High-2.81% Beta1.79
Dividend %- Quick Ratio3.20 Sales past 5Y0.50% Gross Margin47.10% 52W Low100.43% ATR0.25
Employees600 Current Ratio3.20 Sales Q/Q27.00% Oper. Margin-4.10% RSI (14)76.52 Volatility0.50% 1.93%
OptionableYes Debt/Eq0.43 EPS Q/Q-835.80% Profit Margin-8.60% Rel Volume1.37 Prev Close13.90
ShortableYes LT Debt/Eq0.43 EarningsAug 03 AMC Payout- Avg Volume872.26K Price13.85
Recom3.00 SMA204.21% SMA5017.46% SMA20031.28% Volume1,196,091 Change-0.36%
Jul-05-17Downgrade Needham Buy → Hold
Jul-03-17Downgrade Sidoti Buy → Neutral
Feb-08-17Initiated Oppenheimer Outperform $14
Aug-11-16Initiated Loop Capital Hold $9
Jun-02-16Initiated Compass Point Neutral $9
Feb-26-16Upgrade Goldman Sell → Neutral
Feb-25-16Downgrade Topeka Capital Markets Buy → Hold $19 → $9
Feb-25-16Downgrade RBC Capital Mkts Outperform → Sector Perform $16 → $9
Feb-08-16Initiated Sidoti Buy
Nov-23-15Reiterated Needham Buy $14 → $20
Nov-18-15Initiated Topeka Capital Markets Buy $19
Nov-09-15Upgrade BofA/Merrill Neutral → Buy
Aug-05-15Reiterated RBC Capital Mkts Outperform $18 → $15
Jun-22-15Resumed Needham Buy $14
Jun-18-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral $18 → $12
Sep-16-14Downgrade Topeka Capital Markets Hold → Sell
Jun-05-14Upgrade RBC Capital Mkts Sector Perform → Outperform $21
Feb-14-14Reiterated Canaccord Genuity Hold $17 → $20
Oct-31-13Downgrade Stifel Buy → Hold
Sep-30-13Reiterated Stifel Buy $20 → $23
Jul-20-17 08:55AM  Millennial Spending Habits Differ From Older Generations PR Newswire
07:45AM  Bankrate: Mortgage Rates Retreat for Second Week in a Row PR Newswire
Jul-19-17 04:59PM  The Law Offices of Vincent Wong Notifies Investors of an Investigation of Bankrate, Inc. in Connection with the Sale of the Company to Red Ventures Holdco, LP Business Wire
02:40PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bankrate, Inc. (RATE) Accesswire
08:45AM  Real Estate is Americans' Favorite Long-Term Investment PR Newswire
Jul-17-17 02:16PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Bankrate, Inc. to Red Ventures Holdco, LP is Fair to Shareholders RATE Business Wire
Jul-13-17 12:59PM  SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Bankrate, Inc. And Encourages Investors To Contact The Firm For Additional Information Business Wire
Jul-12-17 03:57PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Bankrate, Inc. - RATE PR Newswire
12:58PM  BANKRATE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
10:51AM  Over 44 Million Americans Have a Side Hustle PR Newswire
Jul-11-17 06:06PM  WEISSLAW LLP: Bankrate, Inc. Acquisition May Not Be in the Best Interests of RATE Shareholders PR Newswire
04:09PM  BANKRATE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bankrate, Inc. PR Newswire
09:49AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Bankrate, Inc. to Red Ventures Holdco, LP is Fair to Shareholders Business Wire
07:55AM  Rowley Law PLLC Is Investigating Bankrate, Inc. and Its Board of Directors For Potential Breaches Of Fiduciary Duty PR Newswire
Jul-10-17 07:44PM  Harwood Feffer LLP Announces Investigation of Bankrate, Inc. PR Newswire
Jul-07-17 06:05PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Bankrate, Inc. - RATE Accesswire
Jul-06-17 08:00AM  Bankrate: Mortgage Rates Continue to Rise PR Newswire
Jul-05-17 11:38AM  BANKRATE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Red Ventures May be Unfair to Shareholders Business Wire
11:03AM  Bankrate, Inc. -- Moody's says Bankrate's B1 CFR and stable outlook are not immediately impacted by announcement of pending sale to Red Ventures Moody's
10:34AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bankrate, Inc. (RATE) Accesswire
09:49AM  Company News for July 05, 2017 Zacks
08:45AM  New Cars Unaffordable for Most Americans PR Newswire
08:43AM  CreditCards.com owner Bankrate agrees to $1.4 billion buyout American City Business Journals
08:15AM  Bankrate (RATE) Catches Eye: Stock Jumps 8.6% in Session Zacks
08:15AM  Corporate News Blog - Bankrate to be Acquired by Red Ventures; Set to Generate Greater Scale for Both Businesses Accesswire
Jul-04-17 02:38PM  Bankrate stock pops on $1.4 billion Red Ventures deal American City Business Journals
Jul-03-17 03:43PM  Fiat Chrysler and Bankrate jump while Adobe, Newmont fall Associated Press +8.56%
02:18PM  [$$] Bankrate website to be bought by Red Ventures for $1.24bn Financial Times
01:43PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bankrate, Inc. (RATE) PR Newswire
01:39PM  Why Bankrate Stock Surged 10% Today Motley Fool
01:23PM  [$$] PE-Backed Red Ventures to Acquire Personal Finance Website Bankrate The Wall Street Journal
01:23PM  Why Bankrate, Diamond Offshore Drilling, and Teekay Jumped Today Motley Fool
01:02PM  Bankrate Accepts $1.4 Billion Buyout Offer From Red Ventures Investor's Business Daily
12:46PM  [$$] Bankrate to be Acquired by Marketing Firm Red Ventures The Wall Street Journal
11:35AM  Story Stocks from Briefing.com Briefing.com
10:56AM  Red Ventures buys Bankrate Reuters Videos
10:32AM  Merger Monday: 9 M&A Firecrackers Ahead Of Market Holiday Benzinga
08:32AM  BANKRATE (RATE) ALERT: J&W Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Bankrate, Inc.; Are Shareholders Getting a Fair Price? PR Newswire
08:10AM  Bankrate Acquired by Red Ventures in $1.4 Billion Deal 24/7 Wall St.
08:08AM  Early movers: TSLA, GSK, LVS, WYNN, CAT, GS, BMY & more CNBC
08:01AM  Red Ventures to acquire Bankrate in all-cash deal with an enterprise value of $1.4 billion MarketWatch
07:17AM  Red Ventures to acquire Bankrate for $1.24 bln Reuters
07:13AM  Bankrate to be acquired by Red Ventures for about $1.4 billion in cash CNBC
07:01AM  Bankrate to Be Acquired by Red Ventures for $14.00 per Share PR Newswire
Jun-30-17 11:29AM  Bankrate's Charts Are Shaping Up Nicely TheStreet.com
Jun-29-17 09:46AM  Bankrate: Mortgage Rates Inch Higher PR Newswire
Jun-27-17 09:00AM  Nearly 1 in 4 Has No Emergency Savings PR Newswire
Jun-26-17 08:45AM  Millennials Struggle with Financial Vices PR Newswire
Jun-22-17 04:14PM  Stocks Close Mixed As Health Care Leads; 2 Medicals Hit Buy Points Investor's Business Daily
07:35AM  Bankrate: Mortgage Rates Nudge Higher, But Remain Near 7-Month Lows PR Newswire
Jun-15-17 07:45AM  Bankrate: Mortgage Rates Hovering at 7-Month Lows PR Newswire
Jun-14-17 08:42AM  3 Stocks With LendingTree-Like Return Potential Motley Fool
Jun-08-17 07:45AM  Bankrate: Mortgage Rates Hit 7-Month Low PR Newswire
Jun-07-17 08:45AM  1-in-4 American Families Have Not Sought Medical Attention Due to Cost PR Newswire
Jun-02-17 02:26PM  ETFs with exposure to Bankrate, Inc. : June 2, 2017 Capital Cube
Jun-01-17 07:30AM  Bankrate: Mortgage Rates At Lowest Since Mid-November PR Newswire
May-25-17 08:45AM  Houston is the Best City to Start a Career PR Newswire
07:30AM  Bankrate: Mortgage Rates Hit Six-Month Low PR Newswire
May-23-17 08:45AM  73% Have Financial Regrets PR Newswire
May-17-17 08:45AM  Millennials Think Parents Should Stop Helping with Bills at Earlier Ages PR Newswire -5.99%
May-15-17 04:26PM  ETFs with exposure to Bankrate, Inc. : May 15, 2017 Capital Cube
03:37PM  5 Lowest 7-Year ARM Mortgage Rates TheStreet.com
May-12-17 10:50PM  BANKRATE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Bankrate, Inc. - RATE Business Wire
May-11-17 10:27AM  Bankrate, Inc. :RATE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 11, 2017 Capital Cube
07:30AM  Bankrate: Mortgage Rates Rebound Slightly PR Newswire
May-10-17 08:45AM  42% of Americans Say a Person's Credit Score Affects Romantic Interest PR Newswire
May-09-17 07:56AM  Edited Transcript of RATE earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-04-17 05:22PM  Bankrate Inc. reports 1Q loss Associated Press
04:01PM  Bankrate Reports First Quarter 2017 Financial Results PR Newswire
07:30AM  Bankrate: Mortgage Rates Dawdle Leading Up to Fed Announcement PR Newswire
May-01-17 08:30AM  Mark Hamrick Named 2017-2018 SABEW President PR Newswire
Apr-28-17 10:50PM  BANKRATE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Bankrate, Inc. - RATE Business Wire
05:10PM  Bankrate, Inc. Value Analysis (NYSE:RATE) : April 28, 2017 Capital Cube
Apr-27-17 08:04AM  Bankrate, Inc. breached its 50 day moving average in a Bullish Manner : RATE-US : April 27, 2017 Capital Cube
07:45AM  Bankrate: Mortgage Rates Show Slight Rebound PR Newswire
Apr-26-17 04:15PM  Bankrate, Inc. To Report First Quarter 2017 Earnings On May 4, 2017 PR Newswire
Apr-24-17 08:45AM  Political Climate is Biggest Economic Risk PR Newswire
Apr-20-17 07:45AM  Bankrate: Mortgage Rates Drop to 2017 Lows PR Newswire
Apr-19-17 01:10PM  CreditCards.com Best Travel Credit Cards of Spring 2017 PR Newswire
08:55AM  Wedding Gift-Giving Tendencies Vary by Region PR Newswire
Apr-17-17 03:36PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Bankrate, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
Apr-14-17 10:50PM  BANKRATE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Bankrate, Inc. - RATE PR Newswire
Apr-13-17 07:30AM  Bankrate: Mortgage Rates Slip Amid Geopolitical Tensions PR Newswire
Apr-12-17 08:45AM  3 in 10 Have Never Redeemed Credit Card Rewards PR Newswire
06:00AM  Time Out Group plc ("Time Out", the "Company" or the "Group"): Christine Petersen joins Time Out Digital as CEO PR Newswire
Apr-10-17 08:08AM  4 Top Small-Cap Stocks to Buy This Spring Motley Fool
Apr-06-17 07:30AM  Bankrate: Mortgage Rates Lowest Since Mid-January PR Newswire
Mar-30-17 07:30AM  Bankrate: Mortgage Rates Show Little Change PR Newswire
Mar-29-17 03:11PM  INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Bankrate, Inc. and Encourages Investors With Losses to Contact the Firm Business Wire
08:45AM  Best and Worst States to Retire PR Newswire
Mar-28-17 04:10PM  BANKRATE, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
01:04PM  BANKRATE, INC. Financials
Mar-24-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Bankrate, Inc., BioAmber Inc., Charter Communications, Inc., Citizens, Inc., Global Eagle Entertainment Inc., Patriot National, Inc., SCYNEXIS, Inc. and TCF Financial Corporation PR Newswire
Mar-23-17 09:42AM  Bankrate: Mortgage Rates Reverse Course PR Newswire
Mar-22-17 03:31PM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Bankrate, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
03:14PM  BANKRATE, INC. Files SEC form 10-K, Annual Report
01:18PM  Bankrate, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
Mar-21-17 08:50AM  Americans Feel Better About Savings for First Time in Six Years PR Newswire
05:18AM  5 companies on the radar of a top stock buyback expert MarketWatch
Mar-17-17 11:40PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Bankrate, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
Bankrate, Inc. operates as a publisher, aggregator, and distributor of personal finance content on the Internet. It provides personal finance editorial content across various categories, including credit cards, mortgages, deposits, senior care, and others. The company's flagship Websites CreditCards.com, Bankrate.com, and Caring.com are content destinations and connect its audience with financial service and senior care providers, and contextually relevant advertisers. Its Credit Cards segment offers information and comparison capabilities of consumer and business credit and prepaid cards; and host news and advice on personal finance, credit card, and bank policies, as well as tools and calculators to estimate credit scores and card benefits. The company's Banking segment offers information on rates for various types of mortgages, home lending, and refinancing; and rate information and original editorial content on various deposit products, such as money markets, savings, and certificates of deposit, as well as retirement, taxes, and debt management. This segment also provides original articles on topics related to the housing market and loan refinancing; online analytic tools to calculate investment values; and content on topics, such as retirement 401(k) accounts, social security, tax deductions and exemptions, auto loans, debt consolidation, and credit risk. Its Senior Care segment provides visitors with information on senior care services and support; original articles, helpful tools, and an online senior living community directory, as well as offers a local directory covering a range of other senior caregiving services. Bankrate, Inc. also develops and provides content, tools, Web services, and co-branded Websites to approximately 100 online partners, including personal finance sites. The company was formerly known as ilife.com Inc. and changed its name to Bankrate, Inc. in 2000. Bankrate, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Speltz Christopher JCEO, Credit CardsJun 27Sale12.957339,492279,000Jun 29 04:30 PM
Barnhart StevenSVP, Chief Financial OfficerJun 22Sale12.009,712116,544295,222Jun 23 04:30 PM
Speltz Christopher JCEO, Credit CardsJun 22Sale11.9512,300146,985279,733Jun 23 04:30 PM
Kim Kenneth ScottCEO, Bankrate.comJun 01Sale10.4528,086293,583179,554Jun 05 05:30 PM
Speltz Christopher JCEO, Credit CardsMay 05Sale11.952002,390292,033May 09 05:00 PM
Speltz Christopher JCEO, Credit CardsApr 27Sale10.9512,500136,875292,233Apr 28 05:00 PM
Barnhart StevenSVP, Chief Financial OfficerApr 25Sale10.256,40265,621304,934Apr 25 05:00 PM
Barnhart StevenSVP, Chief Financial OfficerApr 24Sale10.253003,075311,336Apr 25 05:00 PM
Barnhart StevenSVP, Chief Financial OfficerMar 14Sale10.036,70267,238222,703Mar 14 05:53 PM
Barnhart StevenSVP, Chief Financial OfficerMar 13Sale10.255,44055,778229,405Mar 14 05:53 PM
Gilmartin JamesSVP, General CounselMar 13Sale10.355,00051,75087,170Mar 14 05:50 PM
NLNK NewLink Genetics Corporation daily Stock Chart
NLNK [NASD]
NewLink Genetics Corporation
Index- P/E- EPS (ttm)-2.84 Insider Own0.30% Shs Outstand30.61M Perf Week-5.05%
Market Cap224.68M Forward P/E- EPS next Y-2.55 Insider Trans0.00% Shs Float21.66M Perf Month8.74%
Income-82.30M PEG- EPS next Q-0.73 Inst Own57.20% Short Float22.37% Perf Quarter-59.80%
Sales32.80M P/S6.85 EPS this Y-108.00% Inst Trans9.29% Short Ratio5.43 Perf Half Y-31.97%
Book/sh3.91 P/B1.88 EPS next Y16.40% ROA-47.70% Target Price16.00 Perf Year-33.69%
Cash/sh- P/C- EPS next 5Y- ROE-62.00% 52W Range5.90 - 25.17 Perf YTD-28.60%
Dividend- P/FCF- EPS past 5Y0.30% ROI-65.70% 52W High-70.83% Beta1.35
Dividend %- Quick Ratio5.10 Sales past 5Y80.40% Gross Margin- 52W Low24.41% ATR0.38
Employees122 Current Ratio5.10 Sales Q/Q-50.90% Oper. Margin- RSI (14)31.03 Volatility4.99% 5.22%
OptionableYes Debt/Eq0.00 EPS Q/Q12.90% Profit Margin- Rel Volume0.29 Prev Close7.22
ShortableYes LT Debt/Eq0.00 EarningsJul 28 BMO Payout- Avg Volume892.98K Price7.34
Recom2.20 SMA20-1.17% SMA50-28.24% SMA200-46.22% Volume262,839 Change1.66%
Jun-08-17Downgrade Robert W. Baird Outperform → Neutral $25 → $8
Mar-30-17Upgrade SunTrust Hold → Buy
May-11-16Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
May-10-16Reiterated Stifel Buy $63 → $23
May-10-16Reiterated Mizuho Buy $52 → $20
Mar-23-16Initiated Robert W. Baird Outperform $27
Mar-01-16Reiterated Mizuho Buy $62 → $52
Jul-15-15Reiterated Mizuho Buy $50 → $62
Jul-15-15Reiterated Cantor Fitzgerald Buy $44 → $62
May-06-15Reiterated Stifel Buy $59 → $63
Nov-07-14Reiterated Stifel Buy $51 → $55
Sep-12-14Initiated Mizuho Buy $50
Mar-31-14Reiterated MLV & Co Buy $29 → $45
Mar-03-14Downgrade Robert W. Baird Outperform → Neutral
Jan-22-14Reiterated Stifel Buy $31 → $53
Dec-13-13Reiterated Stifel Buy $28 → $31
Sep-30-13Reiterated MLV & Co Buy $24 → $29
Aug-08-13Reiterated Stifel Buy $25 → $28
Aug-08-13Reiterated MLV & Co Buy $18.50 → $24
Jun-04-13Reiterated MLV & Co Buy $18.50 → $24
Jul-12-17 02:48PM  ETFs with exposure to NewLink Genetics Corp. : July 12, 2017 Capital Cube
Jul-10-17 07:00AM  NewLink Genetics Receives Notice of Allowance from USPTO Covering Indoximod Salts and Prodrugs GlobeNewswire
Jul-07-17 07:00AM  NewLink Genetics to Host Its Second Quarter 2017 Financial Results Conference Call on July 28, 2017 GlobeNewswire
Jun-23-17 07:00AM  Positive Phase 1b Data for NewLink Genetics IDO Pathway Inhibitor, Indoximod, in Combination with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Presented at the European Hematologic Association (EHA) Congress in Madrid, Spain GlobeNewswire
Jun-21-17 03:43PM  These 3 Biotechs Have Been Crushed; Is It Time to Bargain Shop? Motley Fool +9.04%
Jun-19-17 08:00AM  A Surprising Disappointment Derails NewLink Genetics -- What's Next? Motley Fool
Jun-13-17 08:49AM  Are Options Traders Betting on a Big Move in NewLink (NLNK) Stock? Zacks
Jun-09-17 04:27PM  Roche-NewLink Drug Move Shouldn't Impact Incyte, Says Analyst Investor's Business Daily
Jun-08-17 05:03PM  Why Sina, Eldorado Gold, and NewLink Genetics Slumped Today Motley Fool -41.24%
04:20PM  Stocks Pull Off Narrow Win, But These Four Soared To New Highs Investor's Business Daily
02:28PM  Why Is NewLink Genetics Losing One-Third of Its Value Today? Motley Fool
09:20AM  NewLink Genetics Sinks After Regaining Licensing Rights for Its Cancer Treatment 24/7 Wall St.
09:20AM  Biotech Movers: NewLink, Inovio, Juno TheStreet.com
08:56AM  NewLink Genetics' stock plunges as Genentech plans to returns rights cancer treatment candidate MarketWatch
07:00AM  NewLink Genetics to Regain Rights to GDC-0919 GlobeNewswire
Jun-05-17 04:50PM  Why Herbalife, JinkoSolar, and NewLink Genetics Slumped Today Motley Fool -12.39%
09:25AM  Biotech Movers: Loxo, NewLink, BioCryst TheStreet.com
09:00AM  NewLink Genetics Indoximod + PROVENGE® Results in Statistically Significant Improvement in Radiographic Progression-Free Survival (rPFS) for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) in Phase 2 Trial GlobeNewswire
Jun-02-17 04:01PM  Results from Clinical Trial of Indoximod Plus Chemotherapy for Patients with Metastatic Breast Cancer GlobeNewswire
06:56AM  Cancer drug prices could double or triple thanks to this popular but unproven drug trend MarketWatch
May-30-17 09:35AM  Update in Lawsuit for Investors in NewLink Genetics Corp (NASDAQ: NLNK) Shares Announced by Shareholders Foundation Accesswire -9.21%
May-18-17 05:32PM  Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer Investor's Business Daily -9.07%
03:33PM  Biotech Stocks: Is ASCO Much Ado About Nothing? Barrons.com
06:00AM  Data from Clinical Study of NewLink Genetics IDO Pathway Inhibitor, Indoximod, to Be Presented at the 22nd European Hematology Association Congress GlobeNewswire
May-17-17 05:05PM  Data from Clinical Studies of NewLink Genetics Two Distinct IDO Pathway Inhibitors to Be Presented at ASCO 2017 GlobeNewswire
May-15-17 09:00PM  Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation - NLNK Business Wire
May-11-17 05:14PM  ETFs with exposure to NewLink Genetics Corp. : May 11, 2017 Capital Cube
May-09-17 10:52AM  NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-08-17 07:00AM  NewLink Genetics to Participate in Upcoming Investor Conferences GlobeNewswire
May-05-17 08:22AM  3 Intriguing Cancer Drugs With Data Coming at ASCO Next Month Motley Fool
May-04-17 09:21AM  NewLink reports 1Q loss Associated Press
08:00AM  NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance GlobeNewswire
07:20AM  Investor Network: Newlink Genetics Corporation to Host Earnings Call Accesswire
May-03-17 07:16PM  Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC. PR Newswire
Apr-25-17 12:34AM  Vaunted Ebola Vaccine Faces Questions The Wall Street Journal
Apr-24-17 06:23PM  Vaunted Ebola Vaccine Faces Questions The Wall Street Journal
Apr-21-17 03:41PM  NewLink Genetics Corp. Value Analysis (NASDAQ:NLNK) : April 21, 2017 Capital Cube
12:02PM  Should Gilead Sciences Acquire NewLink Genetics? Motley Fool
07:00AM  NewLink Genetics Announces Presentation of Two Abstracts at ASCO GlobeNewswire
Apr-20-17 08:20AM  NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : April 20, 2017 Capital Cube
Apr-13-17 12:01PM  Morgan Stanley Ups Incyte Target to $150 Barrons.com
10:41AM  The IDO-Inhibitor Race Is On to Improve Cancer Treatment Motley Fool
08:00AM  NewLink Genetics to Host Its First Quarter 2017 Financial Results Conference Call on May 4, 2017 GlobeNewswire
Apr-07-17 05:08PM  ETFs with exposure to NewLink Genetics Corp. : April 7, 2017 Capital Cube -7.70%
10:17AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : April 7, 2017 Capital Cube
Apr-05-17 04:56PM  Why NewLink Genetics, Harmonic, and Innophos Holdings Slumped Today Motley Fool -14.00%
Apr-04-17 05:07PM  Why NewLink Genetics Shares Fell 10.3% Today Motley Fool -9.96%
04:02PM  NEWLINK GENETICS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In NewLink Genetics Corporation (NLNK) To Contact The Firm Business Wire
09:48AM  NewLink Genetics Corp. stock drops 28% on mid-stage results for melanoma drug MarketWatch
08:30AM  Interim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda® (pembrolizumab) for Patients with Advanced Melanoma at AACR Plenary GlobeNewswire
Mar-31-17 09:30AM  TrovaGene and NewLink Genetics Find Investors Optimistic About Products Accesswire
Mar-30-17 04:07PM  NewLink Genetics' shares surge after upgrade, seen as takeover target CNBC +5.62%
10:33AM  5 Top Performing Stocks of the Best ETF of Q1 Zacks
07:08AM  NewLink Genetics upgraded by SunTrust
Mar-20-17 08:34AM  NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Di
Mar-17-17 08:15AM  Blog Coverage PTC Therapeutics Acquires Rights for Duchenne Muscular Dystrophy Drug from Marathon for $140 Million Upfront Accesswire
Mar-10-17 01:04PM  NEWLINK GENETICS CORP Financials
Mar-07-17 01:23PM  NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Capital Cube -5.21%
Mar-06-17 02:16PM  NEWLINK GENETICS CORP Files SEC form 10-K, Annual Report
07:04AM  Four Companies Breaking Out Right Now With Record Growth
Mar-01-17 05:30PM  NEWLINK GENETICS CORP Files SEC form 8-K, Other Events +6.81%
05:05PM  NewLink Genetics Announces Presentation of Two Abstracts at AACR GlobeNewswire
Feb-28-17 08:45AM  NewLink reports 4Q loss
08:35AM  NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  NewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 NewLink Genetics Corp Earnings Release - Before Market Open
Feb-21-17 10:02AM  NewLink Genetics (NLNK): Moving Average Crossover Alert
Feb-20-17 07:00AM  NewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017 GlobeNewswire
Feb-13-17 05:14PM  [$$] Cevec Pharma, NewLink Genetics Target Zika Through Licensing Deal at The Wall Street Journal
07:00AM  NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th GlobeNewswire
Feb-10-17 03:25AM  Will NewLink Genetics (NLNK) Continue to Surge Higher?
Jan-18-17 03:40PM  Lifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, Natural Health Trends Corp., NeoPhotonics Corporation, NewLink Gen PR Newswire
Jan-11-17 11:19AM  NewLink Genetics Corp. Value Analysis (NASDAQ:NLNK) : January 11, 2017 -5.80%
Jan-10-17 07:18AM  NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : January 10, 2017
Jan-09-17 04:45PM  Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation Business Wire +18.30%
Jan-05-17 05:17PM  NEWLINK GENETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
Dec-27-16 01:31PM  ETFs with exposure to NewLink Genetics Corp. : December 27, 2016
08:30AM  NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session
Dec-23-16 11:42AM  Shark Bites: We Knew Today Would Be Slow, but Come On +9.79%
Dec-20-16 01:49PM  Do Hedge Funds Love Western Asset Mortgage Capital Corp (WMC)? at Insider Monkey
Dec-16-16 02:06PM  ETFs with exposure to NewLink Genetics Corp. : December 16, 2016
Dec-15-16 06:42PM  How Mercantile Bank Corp. (MBWM) Compares To Its Peers at Insider Monkey
Dec-13-16 04:31PM  NEWLINK GENETICS CORP Files SEC form 8-K/A, Termination of a Material Definitive Agreement
Dec-10-16 03:08PM  Hedge Funds Are Dumping Monarch Casino & Resort, Inc. (MCRI) at Insider Monkey
Dec-09-16 03:04PM  Inovio Pharmaceuticals, Inc.'s Biggest Win in 2016 at Motley Fool
Nov-29-16 04:19PM  NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-22-16 07:32AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : November 22, 2016
Nov-21-16 12:41PM  Edited Transcript of NLNK earnings conference call or presentation 1-Nov-16 12:30pm GMT
Nov-15-16 06:55AM  Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
Nov-09-16 07:00AM  NewLink Genetics to Participate in Three Investor Conferences in November GlobeNewswire +10.86%
Nov-08-16 04:19PM  NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report
Nov-03-16 12:18PM  ETFs with exposure to NewLink Genetics Corp. : November 3, 2016
Nov-02-16 10:45AM  NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016 -7.89%
Nov-01-16 09:10AM  NewLink reports 3Q loss
08:17AM  NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 NewLink Genetics Corp Earnings Release - Before Market Open
Oct-31-16 08:33AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : October 31, 2016
Oct-25-16 05:00PM  NEWLINK GENETICS CORP Files SEC form 8-K, Other Events
04:05PM  NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor Day GlobeNewswire
NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products for the treatment of cancer. Its portfolio includes biologic product candidates based on its HyperAcute cellular immunotherapy technology, which is designed to stimulate the human immune system to attack cancer cells; and small-molecule product candidates that are focused on breaking the immune system's tolerance to cancer by inhibiting the indoleamine-2, 3-dioxygenase pathway and the tryptophan-2, 3-dioxygenase pathway. The company is developing IDO pathway inhibitors comprising indoximod that is in multiple Phase I and Phase II clinical trials for patients with melanoma, pancreatic cancer, malignant brain tumors, metastatic breast cancer, acute myeloid leukemia, prostate cancer, and non-small cell lung cancer (NSCLC); and GDC-0919 and atezolizumab (MPDL3280A) that is in Phase Ib clinical trials for patients with locally advanced or metastatic solid tumors. Its clinical development products include NLG2101 for metastatic breast cancer; NLG2102 for refractory malignant brain tumors; NLG2103 for advanced melanoma; NLG2104 for metastatic pancreatic cancer; NLG2105 for pediatric patients with refractory malignant brain tumors; and NLG2106 for acute myelogenous leukemia. The company's HyperAcute cellular immunotherapy product candidates under clinical development include tergenpumatucel-L, is being investigated in Phase Ib/II clinical trial for patients with advanced NSCLC; and dorgenmeltucel-L, is being investigated in a Phase II clinical trial for patients with advanced melanoma. Its infectious disease program includes replication-competent recombinant vesicular stomatitis virus, a vaccine technology to treat Ebola and Marburg viruses. The company has license and collaboration agreements with Genentech, Inc. and Merck, Sharpe and Dohme Corp. NewLink Genetics Corporation was founded in 1999 and is headquartered in Ames, Iowa.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Langren Carl W.Principal Accounting OfficerDec 14Sale10.853,94342,78210,691Dec 16 05:53 PM
VRTS Virtus Investment Partners, Inc. daily Stock Chart
VRTS [NASD]
Virtus Investment Partners, Inc.
Index- P/E17.88 EPS (ttm)6.46 Insider Own4.80% Shs Outstand7.12M Perf Week-2.82%
Market Cap821.65M Forward P/E11.10 EPS next Y10.40 Insider Trans0.00% Shs Float6.71M Perf Month4.06%
Income47.10M PEG0.55 EPS next Q1.68 Inst Own74.70% Short Float10.70% Perf Quarter3.50%
Sales322.00M P/S2.55 EPS this Y58.30% Inst Trans-0.78% Short Ratio13.99 Perf Half Y-3.63%
Book/sh67.49 P/B1.71 EPS next Y38.70% ROA5.00% Target Price118.33 Perf Year41.84%
Cash/sh- P/C- EPS next 5Y32.54% ROE11.10% 52W Range79.84 - 128.10 Perf YTD-2.24%
Dividend1.80 P/FCF21.07 EPS past 5Y-17.60% ROI4.30% 52W High-9.91% Beta1.71
Dividend %1.56% Quick Ratio6.20 Sales past 5Y9.50% Gross Margin- 52W Low44.53% ATR2.87
Employees406 Current Ratio6.20 Sales Q/Q-0.60% Oper. Margin15.00% RSI (14)60.05 Volatility2.53% 2.38%
OptionableNo Debt/Eq0.78 EPS Q/Q11.20% Profit Margin14.60% Rel Volume2.18 Prev Close115.85
ShortableYes LT Debt/Eq0.78 EarningsJul 28 BMO Payout27.10% Avg Volume51.34K Price115.40
Recom3.30 SMA202.93% SMA507.71% SMA2005.64% Volume112,075 Change-0.39%
Jun-01-17Initiated Morgan Stanley Equal-Weight
Jan-31-17Initiated BofA/Merrill Underperform $110
Oct-31-16Downgrade Credit Suisse Outperform → Neutral
Jul-15-16Upgrade Credit Suisse Neutral → Outperform
Mar-10-16Downgrade Jefferies Buy → Hold $99 → $74
Nov-02-15Upgrade Sandler O'Neill Sell → Hold
Sep-01-15Downgrade Sandler O'Neill Hold → Sell
Aug-04-15Downgrade Raymond James Outperform → Mkt Perform
Jul-10-15Downgrade Goldman Neutral → Sell $115
Jul-08-15Downgrade BofA/Merrill Neutral → Underperform
Jun-08-15Initiated Goldman Neutral
Jun-05-15Upgrade Jefferies Hold → Buy
Jun-03-15Initiated Credit Suisse Neutral $142
Sep-05-14Downgrade Furey Research Partners Buy → Fair Value
Jul-13-17 04:05PM  Virtus Investment Partners Reports Preliminary June 30, 2017 Assets Under Management PR Newswire
Jul-05-17 12:41PM  Virtus Total Return Fund Inc. Declares Distribution And Discloses Sources Of Distribution - Section 19(a) Notice PR Newswire
Jul-03-17 02:02PM  Virtus Global Multi-Sector Income Fund Declares Distribution and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
Jun-28-17 10:30AM  Virtus ETF Solutions Launches Alternative ETF PR Newswire
Jun-16-17 08:58AM  Duff & Phelps Global Utility Income Fund Inc. Announces Dividend and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
Jun-15-17 05:00PM  Duff & Phelps Closed-End Funds Announce Dividends PR Newswire
05:00PM  DNP Select Income Fund Announces Dividends And Sources Of Distribution PR Newswire
03:43PM  ETFs with exposure to Virtus Investment Partners, Inc. : June 15, 2017 Capital Cube
Jun-09-17 08:13AM  Virtus Investment Partners, Inc. breached its 50 day moving average in a Bullish Manner : VRTS-US : June 9, 2017 Capital Cube
Jun-07-17 02:44PM  Virtus Total Return Fund Inc. Declares Distribution And Discloses Sources Of Distribution -- Section 19(a) Notice PR Newswire
02:31PM  Virtus Global Multi-Sector Income Fund Declares Distributions and Discloses Sources of Distributions - Section 19(a) Notice PR Newswire
Jun-01-17 02:37PM  Virtus Global Multi-Sector Income Fund Declares Distribution and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
11:20AM  Virtus Investment Partners Completes Acquisition of RidgeWorth Investments PR Newswire
May-24-17 09:40AM  Update in Lawsuit for Investors in Virtus Investment Partners Inc (NASDAQ: VRTS) Shares Announced by Shareholders Foundation Accesswire
May-22-17 09:00AM  Virtus Investment Partners Declares Quarterly Cash Dividends On Common and Preferred Stock PR Newswire
May-12-17 04:40PM  ETFs with exposure to Virtus Investment Partners, Inc. : May 12, 2017 Capital Cube
May-10-17 11:43AM  Virtus Investment Partners, Inc. :VRTS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-08-17 12:18PM  Duff & Phelps Select Income Fund Marks 30th Anniversary PR Newswire
May-05-17 06:18AM  Jobs market chugging along pretty well: Expert CNBC Videos
May-01-17 01:27PM  Virtus Global Multi-Sector Income Fund Declares Distribution and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
08:47AM  Virtus Investment Partners, Inc. breached its 50 day moving average in a Bearish Manner : VRTS-US : May 1, 2017 Capital Cube
Apr-28-17 07:48AM  Virtus posts 1Q profit Associated Press
07:30AM  Virtus Investment Partners Announces Financial Results for the First Quarter 2017 PR Newswire
Apr-27-17 09:58AM  Investment Managers' Earnings on Apr 28: BEN, APO, VRTS Zacks
Apr-26-17 12:10PM  Virtus Investment Partners, Inc. : VRTS-US: Dividend Analysis : April 28th, 2017 (record date) : By the numbers : April 26, 2017 Capital Cube
Apr-24-17 05:05PM  Virtus Investment Partners To Announce First Quarter 2017 Results on April 28 PR Newswire
Apr-15-17 07:00AM  A High-Quality, High-Conviction Small-Cap Fund Morningstar
Apr-12-17 09:05AM  Virtus Investment Partners Reports Preliminary March 31, 2017 Assets Under Management PR Newswire
08:06AM  Virtus Investment Partners, Inc. breached its 50 day moving average in a Bullish Manner : VRTS-US : April 12, 2017 Capital Cube
Apr-03-17 03:33PM  Virtus Global Multi-Sector Income Fund Declares Distribution and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
Mar-30-17 10:00AM  Virtus Chief Market Strategist Joe Terranova to Present Keynote On Capital Markets at Quinnipiac University's G.A.M.E. VII Forum PR Newswire
Mar-27-17 02:56PM  Virtus Multi-Sector Short Term Bond Fund and Virtus International Real Estate Securities Fund Win 2017 Lipper Awards PR Newswire
Mar-14-17 07:30PM  Duff & Phelps Utility and Corporate Bond Trust Announces Dividends PR Newswire
07:22PM  DTF Tax-Free Income Inc. Announces Dividends PR Newswire
07:19PM  DNP Select Income Fund Announces Dividends and Sources of Distribution PR Newswire
05:11PM  Duff & Phelps Global Utility Income Fund Announces Dividend and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
09:28AM  Virtus Total Return Fund Declares Distribution PR Newswire
09:28AM  The Zweig Fund, Inc. Declares Distribution and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
Mar-03-17 01:04PM  VIRTUS INVESTMENT PARTNERS, INC. Financials
Mar-01-17 04:10PM  Virtus Global Multi-Sector Income Fund Declares Distributions and Discloses Sources of Distributions - Section 19(a) Notice PR Newswire
04:08PM  Virtus Global Dividend & Income Fund Inc. Declares Distributions And Discloses Sources Of Distributions - Section 19(a) Notice PR Newswire
Feb-27-17 05:08PM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 10-K, Annual Report
Feb-16-17 05:01PM  Virtus Investment Partners, Inc. -- Moody's assigns first time ratings to Virtus Investment Partners, Inc. at Moody's
09:00AM  Virtus Investment Partners Declares Quarterly Cash Dividends On Common and Preferred Stock PR Newswire
Feb-13-17 12:44PM  Best Kept Contrarian Play: Virtus Investment Partners? at Barrons.com
Feb-01-17 04:42PM  Virtus Global Multi-Sector Income Fund Declares Distribution and Discloses Sources of Distributions - Section 19(a) Notice PR Newswire
04:23PM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modificatio
Jan-31-17 03:40PM  Coverage initiated on Virtus Investment Partners by BofA/Merrill
Jan-27-17 07:55AM  Virtus Investment Partners Prices Public Offerings of Common Stock and Mandatory Convertible Preferred Stock in Connection with Pending Acquisition of RidgeWorth Investments PR Newswire
07:41AM  Virtus Investment Partners, Inc. breached its 50 day moving average in a Bearish Manner : VRTS-US : January 27, 2017
Jan-26-17 11:19AM  Virtus Investment Partners, Inc. :VRTS-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017 -11.54%
Jan-25-17 04:27PM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
04:19PM  Virtus Investment Partners Announces Proposed Public Offerings of Common Stock and Mandatory Convertible Preferred Stock In Connection with Pending Acquisition of RidgeWorth Investments PR Newswire
11:32AM  Edited Transcript of VRTS earnings conference call or presentation 25-Jan-17 3:00pm GMT
08:06AM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
07:53AM  Virtus posts 4Q profit
07:30AM  Virtus Investment Partners Announces Financial Results for the Fourth Quarter 2016 PR Newswire
07:07AM  Q4 2016 Virtus Investment Partners Inc Earnings Release - Before Market Open
Jan-24-17 09:43AM  Marcato Capital urges Virtus to use cash to buy RidgeWorth
08:00AM  Marcato Comments On Virtus' Proposed Acquisition Of Ridgeworth PR Newswire
Jan-20-17 09:23AM  Virtus ETF Solutions Launches Actively Managed ETF With Cumberland Advisors PR Newswire
Jan-19-17 05:51PM  Virtus Investment Partners To Announce Fourth Quarter 2016 Results on January 25 PR Newswire
Jan-17-17 09:15AM  Virtus Investment Partners Reports Preliminary December 31, 2016 Assets Under Management PR Newswire
Jan-03-17 06:31PM  Virtus Global Multi-Sector Income Fund Declares Distributions and Discloses Sources of Distributions - Section 19(a) Notice PR Newswire
06:26PM  Virtus Total Return Fund Declares Distribution PR Newswire
Dec-27-16 11:48AM  Virtus Investment Partners, Inc. : VRTS-US: Dividend Analysis : October 31st, 2016 (record date) : By the numbers : December 27, 2016
Dec-23-16 06:21PM  MoneyGram Focused on Growth; Time to Hold the Stock?
Dec-22-16 05:08PM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:53AM  Why Cullen Frost (CFR) Stock Has Plenty of Upside Left
Dec-21-16 10:52AM  Virtus-RidgeWorth Deal: Boosts AUM, But Headwinds Ahead at Barrons.com
Dec-19-16 09:05AM  Virtus Total Return Fund Authorizes Declaration of a Distribution PR Newswire
09:05AM  Virtus Global Multi-Sector Income Fund Authorizes Declaration of a Distribution PR Newswire
08:25AM  Manning & Napier (MN) in Focus: Stock Moves 5.2% Higher
Dec-16-16 04:46PM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
03:05PM  [$$] Lightyear Selling RidgeWorth Investments to Virtus at The Wall Street Journal
10:03AM  Fund manager Virtus to buy RidgeWorth Investments for $513 mln
09:31AM  Lightyear Capital LLC Announces Sale of RidgeWorth Investments to Virtus Investment Partners, Inc. Business Wire
09:15AM  Virtus Investment Partners Announces Agreement to Acquire RidgeWorth Investments PR Newswire
Dec-15-16 05:09PM  Duff & Phelps Closed-End Funds Announce Dividends PR Newswire
05:01PM  DNP Select Income Fund Announces Dividends And Sources Of Distribution PR Newswire
04:01PM  Duff & Phelps Global Utility Income Fund Announces Dividend and Discloses Sources of Distribution - Section 19(a) Notice PR Newswire
Dec-14-16 01:38PM  Virtus Launches New Active Bond ETF Under Newfleet Banner at Barrons.com
11:09AM  Newfleet Asset Management Launches New Actively Managed ETF PR Newswire
Dec-13-16 06:02AM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements
Dec-12-16 05:52PM  Sheila Hooda Joins Virtus Investment Partners Board PR Newswire
Dec-11-16 07:43AM  Virtus Investment Partners Inc (VRTS) Hedge Funds Are Snapping Up at Insider Monkey
Dec-09-16 08:54AM  Franklin's November AUM Falls on Lower Fixed Income Assets
Dec-08-16 09:30AM  The Zacks Analyst Blog Highlights: Virtus Investment Partners, Woori Bank, Eaton Vance and Eagle Point Credit +5.92%
09:15AM  Virtus Investment Partners Declares Quarterly Cash Dividend PR Newswire
Dec-02-16 04:59PM  Virtus Global Multi-Sector Income Fund Declares Distributions and Discloses Sources of Distributions - Section 19(a) Notice PR Newswire
04:40PM  Virtus Total Return Fund Declares Distribution PR Newswire
Nov-22-16 07:57AM  Why Staying on the Sidelines Is Right for Invesco Stock
Nov-16-16 06:24PM  Why Huntington (HBAN) Is a Great Stock to Buy Right Now
Nov-14-16 04:44PM  Legg Mason (LM) October AUM Declines, Outflows Recorded
Nov-11-16 08:26AM  AllianceBernstein (AB) Catches Eye: Stock Moves 5.8% Higher
Nov-07-16 08:33AM  VIRTUS INVESTMENT PARTNERS, INC. Files SEC form 10-Q, Quarterly Report
Nov-01-16 12:40PM  ETFs with exposure to Virtus Investment Partners, Inc. : November 1, 2016
Oct-31-16 04:10PM  Virtus Investment Partners, Inc.: Strong price momentum but will it sustain?
11:02AM  Virtus Investment Partners, Inc. :VRTS-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
Oct-28-16 02:53PM  Edited Transcript of VRTS earnings conference call or presentation 28-Oct-16 2:00pm GMT +19.82%
Virtus Investment Partners, Inc. is a publicly owned investment manager. The firm primarily provides its services to individual and institutional clients. It launches separate client focused equity and fixed income portfolios. The firm launches equity, fixed income, and balanced mutual funds for its clients. It invests in the public equity, fixed income, and real estate markets. The firm also invests in exchange traded funds. It employs a multi manager approach for its products. The firm employs quantitative analysis to make its investments. It benchmarks the performance of its portfolios against the S&P 500 Index. The firm conducts in-house research to make its investments. Virtus Investment Partners, Inc. was founded in 1988 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AYLWARD GEORGE RDirector, CEO and PresidentFeb 08Option Exercise40.008,399335,960155,019Feb 09 06:54 PM
AYLWARD GEORGE RDirector, CEO and PresidentFeb 07Option Exercise40.002,500100,000146,620Feb 09 06:54 PM
MNTA Momenta Pharmaceuticals, Inc. daily Stock Chart
MNTA [NASD]
Momenta Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.42 Insider Own1.30% Shs Outstand75.73M Perf Week0.00%
Market Cap1.31B Forward P/E- EPS next Y-0.79 Insider Trans-3.11% Shs Float69.04M Perf Month0.29%
Income-28.80M PEG- EPS next Q-0.50 Inst Own92.40% Short Float7.58% Perf Quarter30.19%
Sales116.40M P/S11.22 EPS this Y76.80% Inst Trans0.12% Short Ratio6.36 Perf Half Y16.95%
Book/sh5.31 P/B3.25 EPS next Y45.50% ROA-6.30% Target Price15.71 Perf Year47.69%
Cash/sh5.73 P/C3.01 EPS next 5Y- ROE-8.20% 52W Range10.50 - 19.90 Perf YTD14.62%
Dividend- P/FCF25.51 EPS past 5Y-15.80% ROI-20.10% 52W High-13.32% Beta1.83
Dividend %- Quick Ratio4.10 Sales past 5Y-17.30% Gross Margin- 52W Low64.29% ATR0.55
Employees290 Current Ratio4.10 Sales Q/Q33.70% Oper. Margin-71.20% RSI (14)57.53 Volatility3.08% 2.97%
OptionableYes Debt/Eq0.00 EPS Q/Q-29.60% Profit Margin-24.70% Rel Volume0.49 Prev Close16.90
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout- Avg Volume823.10K Price17.25
Recom2.90 SMA200.36% SMA506.26% SMA20016.38% Volume401,662 Change2.07%
May-22-17Downgrade Barclays Overweight → Equal Weight $20 → $17
Feb-22-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-31-17Reiterated Barclays Overweight $19 → $20
Nov-22-16Initiated Aegis Capital Hold
Oct-11-16Upgrade Barclays Equal Weight → Overweight $13 → $19
Sep-07-16Downgrade Maxim Group Hold → Sell $6
Jun-06-16Initiated Goldman Neutral $14
Jan-08-16Upgrade Maxim Group Sell → Hold
Nov-13-15Initiated JP Morgan Overweight
Aug-06-15Downgrade Goldman Buy → Neutral
Jun-19-15Reiterated Stifel Buy $26 → $29
Jun-19-15Reiterated Brean Capital Buy $25 → $31
Jun-04-15Initiated Stifel Buy $26
Apr-17-15Reiterated Leerink Partners Outperform $16 → $24
Apr-17-15Reiterated Brean Capital Buy $15 → $25
Feb-18-15Reiterated UBS Buy $18 → $15
Jan-23-15Downgrade Maxim Group Buy → Sell $17 → $7
Jan-08-15Initiated Brean Capital Buy $15
Jun-05-14Resumed Maxim Group Buy $24 → $17
May-09-14Initiated Maxim Group Buy $24
Jul-19-17 08:00AM  Momenta Pharmaceuticals Announces Date of Second Quarter 2017 Financial Results Conference Call and Webcast GlobeNewswire
Jul-10-17 02:53PM  ETFs with exposure to Momenta Pharmaceuticals, Inc. : July 10, 2017 Capital Cube
Jun-27-17 03:26PM  ETFs with exposure to Momenta Pharmaceuticals, Inc. : June 27, 2017 Capital Cube
Jun-15-17 12:15PM  Mylan In FDA Limbo On Generic Multiple Sclerosis Drug Investor's Business Daily
Jun-13-17 08:53AM  Implied Volatility Surging for Momenta Pharmaceuticals (MNTA) Stock Options Zacks
Jun-12-17 02:14PM  ETFs with exposure to Momenta Pharmaceuticals, Inc. : June 12, 2017 Capital Cube
Jun-09-17 09:23AM  Momenta Pharmaceuticals, Inc. :MNTA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 Capital Cube
Jun-07-17 08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 38th Annual Global Healthcare Conference GlobeNewswire +5.74%
Jun-05-17 04:17AM  Why Is Momenta Pharmaceuticals (MNTA) Down 9.7% Since the Last Earnings Report? Zacks
Jun-01-17 08:00AM  Momenta Pharmaceuticals Appoints Santiago Arroyo, M.D., Ph.D. as Chief Medical Officer GlobeNewswire
May-31-17 11:44AM  Novartis CEO sees no need for big takeover Reuters
May-10-17 04:05PM  UPDATE -- Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences GlobeNewswire -5.31%
08:00AM  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences GlobeNewswire
May-04-17 03:25PM  Edited Transcript of MNTA earnings conference call or presentation 2-May-17 2:00pm GMT Thomson Reuters StreetEvents
May-03-17 04:19PM  Momenta Pharmaceuticals, Inc. Looks for Some Momentum Motley Fool
10:32AM  Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat Zacks
May-02-17 05:23PM  Momenta Pharmaceuticals, Inc. Value Analysis (NASDAQ:MNTA) : May 2, 2017 Capital Cube +7.14%
08:07AM  Momenta reports 1Q loss Associated Press
08:00AM  Momenta Pharmaceuticals Reports First Quarter 2017 Financial Results GlobeNewswire
07:55AM  Investor Network: Momenta Pharmaceuticals, Inc. to Host Earnings Call Accesswire
May-01-17 08:09AM  Momenta Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : MNTA-US : May 1, 2017 Capital Cube
Apr-26-17 08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 42nd Annual Health Care Conference GlobeNewswire
Apr-18-17 08:00AM  Momenta Pharmaceuticals Announces Date of First Quarter 2017 Financial Results Conference Call and Webcast GlobeNewswire
Mar-29-17 07:00AM  Why Is Momenta (MNTA) Down 9.6% Since the Last Earnings Report? Zacks
07:00AM  Why Is Momenta (MNTA) Down 9.6% Since the Last Earnings Report? at Investopedia
Mar-24-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc. PR Newswire
Mar-17-17 04:06PM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fina
Mar-08-17 07:52AM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Mar-07-17 11:09AM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA PR Newswire
Mar-02-17 01:04PM  MOMENTA PHARMACEUTICALS INC Financials
Feb-28-17 03:29PM  FDA warns Pfizer over contaminated drugs at Kansas plant Reuters
08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-24-17 04:56PM  MOMENTA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
11:28AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Momenta Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
10:30AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Momenta Pharmaceuticals, Inc. Investors Business Wire
Feb-23-17 03:58PM  Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat Motley Fool
03:58PM  Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat at Motley Fool
09:45AM  [2/23] Today's Top 10 Long/Short Estimize Signal Scores
08:59AM  Clovis (CLVS) Q4 Loss Wider than Expected; Focus on Rubraca Zacks
Feb-22-17 03:13PM  Momenta Tops Q4 Earnings, Shares Down on Warning Letter -5.92%
02:33PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Momenta Pharmaceuticals, Inc., and Encourages Investors to Contact the Firm Business Wire
02:02PM  Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA) at Insider Monkey
12:16PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA Business Wire
11:05AM  Momenta 4Q Net 60 Cents a Share at Investopedia
10:30AM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Momenta Pharmaceuticals, Inc. Investors Business Wire
10:24AM  Momenta Pharmaceuticals, Inc. :MNTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Momenta Pharmaceuticals, Inc. (MNTA) PR Newswire
08:18AM  Momenta Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : MNTA-US : February 22, 2017
08:03AM  Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More
Feb-21-17 04:45PM  Why Momenta Pharmaceuticals, Northern Dynasty Minerals, and Unilever Slumped Today at Motley Fool -15.53%
04:27PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Momenta Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
04:22PM  Edited Transcript of MNTA earnings conference call or presentation 21-Feb-17 1:00pm GMT
01:37PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Momenta Pharmaceuticals, Inc. - MNTA PR Newswire
12:37PM  Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug
12:26PM  Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today at Motley Fool
11:35AM  Momenta shares plunge after supplier receives warning letter from FDA on multiple sclerosis drug at CNBC
10:20AM  Momenta Pharma's Supply Partner Gets FDA Warning at Investopedia
10:09AM  Sarepta Leads Biotech Movers on Voucher Deal News
09:35AM  Momenta beats Street 4Q forecasts
07:07AM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
07:07AM  Q4 2016 Momenta Pharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results GlobeNewswire
Feb-20-17 06:52AM  Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS
Feb-17-17 06:41PM  Momenta Pharma shares halted as drug application hits speed bump at MarketWatch
06:05PM  Momenta Pharmaceuticals Announces Time Change for Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast GlobeNewswire
06:00PM  Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer GlobeNewswire
08:00AM  Momenta Pharmaceuticals Announces HSR Clearance for Collaboration and License Agreement with CSL GlobeNewswire
Feb-14-17 09:30AM  The Zacks Analyst Blog Highlights: MidWestOne Financial Group, Brooks Automation, Cross Country Healthcare, Francesca's Holdings and Momenta Pharmaceuticals
Feb-13-17 09:14AM  Forget Gilead, Buy These 5 Biotech Stocks Instead
08:53AM  5 Stocks to Buy as Trump Chalks Out 'Phenomenal' Tax Plan
07:02AM  Teva Pharm Q4 profit, revenue beat expectations Reuters
Feb-10-17 03:24AM  Can The Uptrend Continue for Momenta Pharmaceuticals (MNTA)?
Feb-07-17 08:00AM  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast GlobeNewswire
Feb-01-17 10:11AM  Momenta Says District of Delaware Invalidates Teva's MS Drug
09:45AM  Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on AEterna Zentaris and Momenta Pharmaceuticals Accesswire
08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the Leerink Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-31-17 06:30PM  Why Momenta Pharmaceuticals, Ally Financial, and Thermo Fisher Scientific Jumped Today at Motley Fool +25.17%
01:03PM  Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today at Motley Fool
11:58AM  Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip? at Motley Fool
11:16AM  Mylan's Shares Rise Despite FTC Investigation
09:27AM  Premarket Biotech Movers: Mylan, Momenta Pharmaceuticals, Seres Therapeutics
08:00AM  Momenta Pharmaceuticals Announces District Court Decision to Invalidate Teva Pharmaceuticals Patents in COPAXONE® (glatiramer acetate injection) 40 mg/mL Litigation GlobeNewswire
Jan-24-17 10:33AM  Momenta Pharmaceuticals, Inc. Value Analysis (NASDAQ:MNTA) : January 24, 2017
Jan-23-17 08:24AM  Momenta Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : MNTA-US : January 23, 2017
Jan-13-17 09:06AM  Mylans Recent Commercial and Product Developments
Jan-09-17 09:15AM  Biotech Industry Off to a Strong Start in 2017 Latest Reports on Sarepta Therapeutics and Momenta Pharmaceuticals Accesswire
07:39AM  Teva Falls on Disappointing 2017 Sales & Earnings Guidance
Jan-06-17 06:44PM  Momenta (MNTA) to Receive $50M Under CSL Collaboration +5.81%
02:00PM  Cambridge's Momenta sees shares jump on $50M drug development deal at bizjournals.com
08:23AM  Momenta stock rises 4% on corporate update at MarketWatch
08:09AM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financia
08:00AM  Momenta Provides Year-End 2016 Corporate Update GlobeNewswire
Jan-05-17 04:11PM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
04:01PM  Momenta and CSL Announce Collaboration and License Agreement to Develop Fc Multimer Programs, Including M230, a Selective Immunomodulator of Fc Receptors GlobeNewswire
02:40PM  Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference at bizjournals.com
Jan-03-17 08:04AM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the 35th Annual J. P. Morgan Healthcare Conference GlobeNewswire
Dec-21-16 04:44PM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Dec-16-16 05:13PM  MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Dec-07-16 09:05AM  Teva Copaxone EU Label to Omit Pregnancy Contraindication
Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for autoimmune diseases in the United States. The company's complex generics programs include Enoxaparin sodium injection, a generic version of Lovenox that is indicated for the prevention and treatment of deep vein thrombosis, as well as supports the treatment of acute coronary syndromes; GLATOPA, a generic version of once-daily COPAXONE for the treatment of patients with relapsing-remitting multiple sclerosis; and GLATOPA, a generic product candidate for three-times-weekly COPAXONE. Its biosimilars programs comprise M923, a biosimilar of HUMIRA for the treatment of patients with rheumatoid arthritis, crohn's disease, ulcerative colitis, and psoriasis; and M834, a biosimilar of ORENCIA for the treatment of rheumatoid arthritis and juvenile idiopathic arthritis, as well as other biosimilar candidates. The company's novel therapeutics programs include M254, a hyper-sialylated version of intravenous immunoglobulin to treat various inflammatory diseases, including idiopathic thrombocytopenic purpura, Kawasaki disease, and chronic inflammatory demyelinating polyneuropathy; M281, a fully-human monoclonal antibody that blocks the neonatal Fc receptor; and M230, a selective immunomodulator of Fc receptors candidate. It has collaboration and license agreements with Sandoz AG, Mylan Ireland Limited, and CSL Behring Recombinant Facility AG. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leicher BruceSVP & General CounselMay 22Sale14.8085912,713174,342May 23 02:47 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchMay 19Sale15.9082113,054489,629May 23 02:51 PM
WHEELER CRAIG APresidentMay 19Sale15.834,11665,156279,861May 23 02:49 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchMay 10Sale16.003846,144490,453May 12 02:13 PM
Leicher BruceSVP & General CounselMay 10Sale16.003475,552175,205May 12 02:14 PM
WHEELER CRAIG APresidentMay 10Sale15.771,85229,206283,977May 12 02:13 PM
WHEELER CRAIG APresidentFeb 22Sale15.515,62687,259301,365Feb 24 06:35 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchFeb 22Sale15.601,06916,676490,837Feb 24 06:24 PM
Leicher BruceSVP & General CounselFeb 22Sale15.601,05016,380175,552Feb 24 06:19 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchFeb 10Sale18.901,75633,188491,906Feb 14 05:42 PM
Leicher BruceSVP & General CounselFeb 10Sale18.901,62030,618176,602Feb 14 05:33 PM
WHEELER CRAIG APresidentFeb 10Sale18.857,088133,609306,991Feb 14 05:38 PM
Leicher BruceSVP & General CounselJan 31Sale18.005,00090,000178,222Feb 02 03:54 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchJan 09Option Exercise9.4539,647374,784493,662Jan 10 03:34 PM
Shea Richard PSVP, CFODec 15Sale15.009,799146,985119,906Dec 16 03:41 PM
Shea Richard PSVP, CFODec 09Sale15.001,45121,765129,705Dec 12 04:32 PM
Leicher BruceSVP & General CounselNov 22Sale14.402273,269182,576Nov 23 10:32 AM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchNov 22Sale14.402273,269454,015Nov 23 10:36 AM
Roach James M.Senior VP, Development and ChiNov 22Sale14.402503,600155,381Nov 23 10:41 AM
Shea Richard PSVP, CFONov 22Sale14.402273,269131,156Nov 23 10:46 AM
WHEELER CRAIG APresidentNov 22Sale14.051,76424,784320,699Nov 23 10:52 AM
WHEELER CRAIG APresidentNov 21Sale13.524,11655,648322,463Nov 23 10:52 AM
Shea Richard PSVP, CFONov 21Sale13.4574410,007131,383Nov 23 10:46 AM
Roach James M.Senior VP, Development and ChiNov 21Sale13.4584111,311155,631Nov 23 10:41 AM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchNov 21Sale13.4582111,042454,242Nov 23 10:36 AM
Leicher BruceSVP & General CounselNov 21Sale13.4580310,800182,803Nov 23 10:32 AM
WHEELER CRAIG APresidentAug 22Sale12.001,76421,168333,199Aug 23 05:05 PM
Shea Richard PSVP, CFOAug 22Sale12.102272,747132,127Aug 23 05:26 PM
Leicher BruceSVP & General CounselAug 22Sale12.102272,747182,952Aug 23 05:28 PM
Roach James M.Senior VP, Development and ChiAug 22Sale12.102493,013156,472Aug 23 05:30 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchAug 22Sale12.102272,747455,063Aug 23 05:33 PM
Kaundinya Ganesh VenkataramanSenior V.P., ResearchAug 19Sale12.048229,897455,290Aug 23 05:33 PM
Roach James M.Senior VP, Development and ChiAug 19Sale12.0484210,138156,721Aug 23 05:30 PM
Leicher BruceSVP & General CounselAug 19Sale12.048039,668183,179Aug 23 05:28 PM
Shea Richard PSVP, CFOAug 19Sale12.047458,970132,354Aug 23 05:26 PM
WHEELER CRAIG APresidentAug 19Sale12.044,11649,536334,963Aug 23 05:05 PM